Immunohistochemical study using a well-characterized panel of antibodies to p16, p53 and Ki-67 could pose a challenge, while it may be helpful in distinguishing STUMP from usual leiomyoma and leiomyosarcoma cases (Tables I and III). The gene discussed is CDKN2A; the disease is leiomyosarcoma.